118 related articles for article (PubMed ID: 35970044)
21. Clinicopathologic features and prognostic implications of NOK/STYK1 protein expression in non-small cell lung cancer.
Chen P; Li WM; Lu Q; Wang J; Yan XL; Zhang ZP; Li XF
BMC Cancer; 2014 Jun; 14():402. PubMed ID: 24894011
[TBL] [Abstract][Full Text] [Related]
22. TLR2 Expression on Leukemic B Cells from Patients with Chronic Lymphocytic Leukemia.
Szymańska A; Bojarska-Junak A; Drobiecki A; Tomczak W; Roliński J; Hus M; Hus I
Arch Immunol Ther Exp (Warsz); 2019 Feb; 67(1):55-65. PubMed ID: 30196472
[TBL] [Abstract][Full Text] [Related]
23. STYK1/NOK Promotes Metastasis and Epithelial-Mesenchymal Transition in Non-small Cell Lung Cancer by Suppressing FoxO1 Signaling.
Lai Y; Lin F; Wang X; Zhang J; Xia J; Sun Y; Wen M; Li X; Zhang Z; Zhao J
Front Cell Dev Biol; 2021; 9():621147. PubMed ID: 34295886
[TBL] [Abstract][Full Text] [Related]
24. PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model.
Motiwala T; Kutay H; Zanesi N; Frissora FW; Mo X; Muthusamy N; Jacob ST
Leukemia; 2015 Jun; 29(6):1350-9. PubMed ID: 25482129
[TBL] [Abstract][Full Text] [Related]
25. Differential sensitivity of CD4+ and CD8+ T lymphocytes to the killing efficacy of Fas (Apo-1/CD95) ligand+ tumor cells in B chronic lymphocytic leukemia.
Tinhofer I; Marschitz I; Kos M; Henn T; Egle A; Villunger A; Greil R
Blood; 1998 Jun; 91(11):4273-81. PubMed ID: 9596676
[TBL] [Abstract][Full Text] [Related]
26. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
Wang Z; Qu L; Deng B; Sun X; Wu S; Liao J; Fan J; Peng Z
Sci Rep; 2016 Sep; 6():33205. PubMed ID: 27628214
[TBL] [Abstract][Full Text] [Related]
27. ROR1 can interact with TCL1 and enhance leukemogenesis in Eμ-TCL1 transgenic mice.
Widhopf GF; Cui B; Ghia EM; Chen L; Messer K; Shen Z; Briggs SP; Croce CM; Kipps TJ
Proc Natl Acad Sci U S A; 2014 Jan; 111(2):793-8. PubMed ID: 24379361
[TBL] [Abstract][Full Text] [Related]
28. Serine threonine tyrosine kinase 1 is a potential prognostic marker in colorectal cancer.
Hu L; Chen HY; Cai J; Zhang Y; Qi CY; Gong H; Zhai YX; Fu H; Yang GZ; Gao CF
BMC Cancer; 2015 Apr; 15():246. PubMed ID: 25884558
[TBL] [Abstract][Full Text] [Related]
29. Identification of Distinct Unmutated Chronic Lymphocytic Leukemia Subsets in Mice Based on Their T Cell Dependency.
Pal Singh S; de Bruijn MJW; de Almeida MP; Meijers RWJ; Nitschke L; Langerak AW; Pillai SY; Stadhouders R; Hendriks RW
Front Immunol; 2018; 9():1996. PubMed ID: 30271400
[TBL] [Abstract][Full Text] [Related]
30. Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia.
Johnson AJ; Lucas DM; Muthusamy N; Smith LL; Edwards RB; De Lay MD; Croce CM; Grever MR; Byrd JC
Blood; 2006 Aug; 108(4):1334-8. PubMed ID: 16670263
[TBL] [Abstract][Full Text] [Related]
31. Aberrantly High Expression Of NOK/STYK1 Is Tightly Associated With The Activation Of The AKT/GSK3β/N-Cadherin Pathway In Non-Small Cell Lung Cancer.
Huang Z; Ma N; Xiong YL; Wang L; Li WM; Lai YY; Zhang CX; Zhang ZP; Li XF; Zhao JB
Onco Targets Ther; 2019; 12():10299-10309. PubMed ID: 31819514
[TBL] [Abstract][Full Text] [Related]
32. Aberrant expression of STYK1 and E-cadherin confer a poor prognosis for pancreatic cancer patients.
Chen L; Ma C; Bian Y; Shao C; Wang T; Li J; Chong X; Su L; Lu J
Oncotarget; 2017 Dec; 8(67):111333-111345. PubMed ID: 29340057
[TBL] [Abstract][Full Text] [Related]
33. Knockdown of Serine Threonine Tyrosine Kinase 1 (STYK1) Inhibits the Migration and Tumorigenesis in Glioma Cells.
Zhou J; Wang F; Liu B; Yang L; Wang X; Liu Y
Oncol Res; 2017 Jul; 25(6):931-937. PubMed ID: 27983928
[TBL] [Abstract][Full Text] [Related]
34. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression.
Bichi R; Shinton SA; Martin ES; Koval A; Calin GA; Cesari R; Russo G; Hardy RR; Croce CM
Proc Natl Acad Sci U S A; 2002 May; 99(10):6955-60. PubMed ID: 12011454
[TBL] [Abstract][Full Text] [Related]
35. Constitutive activation of Lyn kinase enhances BCR responsiveness, but not the development of CLL in Eµ-TCL1 mice.
Kohlhas V; Hallek M; Nguyen PH
Blood Adv; 2020 Dec; 4(24):6106-6116. PubMed ID: 33351104
[TBL] [Abstract][Full Text] [Related]
36. Chronic lymphocytic leukemia cells in a lymph node microenvironment depict molecular signature associated with an aggressive disease.
Mittal AK; Chaturvedi NK; Rai KJ; Gilling-Cutucache CE; Nordgren TM; Moragues M; Lu R; Opavsky R; Bociek GR; Weisenburger DD; Iqbal J; Joshi SS
Mol Med; 2014 Jul; 20(1):290-301. PubMed ID: 24800836
[TBL] [Abstract][Full Text] [Related]
37. STYK1 promotes the malignant progression of laryngeal squamous cell carcinoma through targeting TGF-β1.
Li XL; Huang YY; Yuan TJ; Lian XP; Bi HL
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6166-6174. PubMed ID: 32572882
[TBL] [Abstract][Full Text] [Related]
38. Point mutation at single tyrosine residue of novel oncogene NOK abrogates tumorigenesis in nude mice.
Chen Y; Li YH; Chen XP; Gong LM; Zhang SP; Chang ZJ; Zhang XF; Fu XY; Liu L
Cancer Res; 2005 Dec; 65(23):10838-46. PubMed ID: 16322230
[TBL] [Abstract][Full Text] [Related]
39. Accelerated progression of chronic lymphocytic leukemia in Eμ-TCL1 mice expressing catalytically inactive RAG1.
Nganga VK; Palmer VL; Naushad H; Kassmeier MD; Anderson DK; Perry GA; Schabla NM; Swanson PC
Blood; 2013 May; 121(19):3855-66, S1-16. PubMed ID: 23502221
[TBL] [Abstract][Full Text] [Related]
40. STYK1 promotes tumor growth and metastasis by reducing SPINT2/HAI-2 expression in non-small cell lung cancer.
Ma Z; Liu D; Li W; Di S; Zhang Z; Zhang J; Xu L; Guo K; Zhu Y; Han J; Li X; Yan X
Cell Death Dis; 2019 Jun; 10(6):435. PubMed ID: 31164631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
